Interpace Biosciences OTC Stock Forward View
| IDXG Stock | USD 1.71 0.18 9.52% |
Interpace OTC Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Interpace Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 3rd of February 2026, The value of RSI of Interpace Biosciences' share price is at 59. This usually indicates that the otc stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Interpace Biosciences, making its price go up or down. Momentum 59
Buy Extended
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate signals. We use our internally-built news screening methodology to estimate the value of Interpace Biosciences based on different types of headlines from major news networks to social media. Using Interpace Biosciences hype-based prediction, you can estimate the value of Interpace Biosciences from the perspective of Interpace Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Interpace Biosciences on the next trading day is expected to be 1.80 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 7.39. Interpace Biosciences after-hype prediction price | USD 1.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Interpace |
Interpace Biosciences Additional Predictive Modules
Most predictive techniques to examine Interpace price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Interpace using various technical indicators. When you analyze Interpace charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Interpace Biosciences Naive Prediction Price Forecast For the 4th of February
Given 90 days horizon, the Naive Prediction forecasted value of Interpace Biosciences on the next trading day is expected to be 1.80 with a mean absolute deviation of 0.12, mean absolute percentage error of 0.02, and the sum of the absolute errors of 7.39.Please note that although there have been many attempts to predict Interpace OTC Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Interpace Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Interpace Biosciences OTC Stock Forecast Pattern
| Backtest Interpace Biosciences | Interpace Biosciences Price Prediction | Research Analysis |
Interpace Biosciences Forecasted Value
In the context of forecasting Interpace Biosciences' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Interpace Biosciences' downside and upside margins for the forecasting period are 0.02 and 11.28, respectively. We have considered Interpace Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Interpace Biosciences otc stock data series using in forecasting. Note that when a statistical model is used to represent Interpace Biosciences otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.0378 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1192 |
| MAPE | Mean absolute percentage error | 0.1018 |
| SAE | Sum of the absolute errors | 7.3893 |
Predictive Modules for Interpace Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Interpace Biosciences. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Interpace Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Interpace Biosciences After-Hype Price Density Analysis
As far as predicting the price of Interpace Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Interpace Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Interpace Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Interpace Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Interpace Biosciences' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Interpace Biosciences' historical news coverage. Interpace Biosciences' after-hype downside and upside margins for the prediction period are 0.09 and 11.19, respectively. We have considered Interpace Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Interpace Biosciences is abnormally volatile at this time. Analysis and calculation of next after-hype price of Interpace Biosciences is based on 3 months time horizon.
Interpace Biosciences OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Interpace Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Interpace Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Interpace Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.30 | 9.48 | 0.00 | 0.01 | 0 Events / Month | 1 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.71 | 1.71 | 0.00 |
|
Interpace Biosciences Hype Timeline
Interpace Biosciences is currently traded for 1.71. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Interpace is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 1.3%. %. The volatility of related hype on Interpace Biosciences is about 158000.0%, with the expected price after the next announcement by competition of 1.72. About 28.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.12. Interpace Biosciences last dividend was issued on the 15th of January 2020. The entity had 1:10 split on the 15th of January 2020. Given the investment horizon of 90 days the next anticipated press release will be uncertain. Check out Historical Fundamental Analysis of Interpace Biosciences to cross-verify your projections.Interpace Biosciences Related Hype Analysis
Having access to credible news sources related to Interpace Biosciences' direct competition is more important than ever and may enhance your ability to predict Interpace Biosciences' future price movements. Getting to know how Interpace Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Interpace Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RNVA | Rennova Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TDSGF | Telo Genomics Corp | 0.00 | 0 per month | 7.23 | (0) | 15.63 | (15.00) | 48.57 | |
| ICBU | Imd Companies | 0.00 | 0 per month | 9.74 | 0.04 | 30.77 | (20.00) | 83.53 | |
| AVCRF | Avricore Health | 0.06 | 5 per month | 16.75 | 0.11 | 46.33 | (33.55) | 115.37 | |
| RSCF | Reflect Scientific | 0.00 | 0 per month | 0.00 | 0.03 | 20.00 | (16.67) | 45.00 | |
| SLDX | JMD Properties | 0.00 | 0 per month | 0.00 | 0.05 | 0.00 | (5.00) | 182.35 | |
| RMSL | REMSleep Holdings | 0.00 | 0 per month | 6.50 | 0.13 | 23.81 | (12.77) | 278.33 | |
| LIFD | LFTD Partners | 0.00 | 0 per month | 8.62 | 0.03 | 21.74 | (21.43) | 72.22 | |
| CPIVF | Captiva Verde Land | 0.00 | 0 per month | 25.63 | 0.24 | 127.27 | (58.95) | 216.41 | |
| RVVTF | Revive Therapeutics | 0.00 | 0 per month | 11.04 | 0.05 | 31.82 | (22.22) | 93.33 |
Other Forecasting Options for Interpace Biosciences
For every potential investor in Interpace, whether a beginner or expert, Interpace Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Interpace OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Interpace. Basic forecasting techniques help filter out the noise by identifying Interpace Biosciences' price trends.Interpace Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Interpace Biosciences otc stock to make a market-neutral strategy. Peer analysis of Interpace Biosciences could also be used in its relative valuation, which is a method of valuing Interpace Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Interpace Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Interpace Biosciences otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Interpace Biosciences shares will generate the highest return on investment. By undertsting and applying Interpace Biosciences otc stock market strength indicators, traders can identify Interpace Biosciences entry and exit signals to maximize returns.
Interpace Biosciences Risk Indicators
The analysis of Interpace Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Interpace Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting interpace otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.08 | |||
| Semi Deviation | 5.64 | |||
| Standard Deviation | 9.12 | |||
| Variance | 83.1 | |||
| Downside Variance | 44.12 | |||
| Semi Variance | 31.82 | |||
| Expected Short fall | (8.42) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Interpace Biosciences
The number of cover stories for Interpace Biosciences depends on current market conditions and Interpace Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Interpace Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Interpace Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Other Information on Investing in Interpace OTC Stock
Interpace Biosciences financial ratios help investors to determine whether Interpace OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Interpace with respect to the benefits of owning Interpace Biosciences security.